Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-12 10:40 am Purchase | 13G | Zenas BioPharma Inc. ZBIO | FMR LLC | 2,000,000 5.026% | 2,000,000 (New Position) | View |
| 2024-10-21 4:18 pm Purchase | 13G | Zenas BioPharma Inc. ZBIO | Xencor Inc XNCR | 3,098,380 7.400% | 3,098,380 (New Position) | View |
| 2024-09-25 6:00 pm Purchase | 13G | Zenas BioPharma Inc. ZBIO | NEA 18 Venture Growth Equity L.P. | 2,613,948 6.600% | 2,613,948 (New Position) | View |
| 2024-09-23 8:56 pm Purchase | 13D | Zenas BioPharma Inc. ZBIO | SR ONE CAPITAL MANAGEMENT LLC | 4,911,539 12.300% | 4,911,539 (New Position) | View |
| 2024-09-23 8:11 pm Purchase | 13D | Zenas BioPharma Inc. ZBIO | Longitude Capital Partners IV LLC | 2,501,934 6.000% | 2,501,934 (New Position) | View |
| 2024-09-23 4:16 pm Purchase | 13D | Zenas BioPharma Inc. ZBIO | Enavate Sciences GP LLC | 3,761,359 9.000% | 3,761,359 (New Position) | View |